Clinical Trial Update: Effects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive Subjects [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effects of an SGLT2 inhibitor on hemodynamic parameters in subjects with resistant hypertension, including patients with ty…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Hypertrophy
• Hypertension
• Microalbuminuria
• Obesity
• Type 2 Diabetes Mellitus
• Vascular Stiffness

Drugs mentioned

• SGLT2 inhibitor

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Hypertension, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED